FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 169 filers reported holding FATE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 9.78 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,586 | -63.0% | 10,182 | -0.4% | 0.00% | – |
| Q1 2023 | $58,300 | -99.2% | 10,228 | -98.7% | 0.00% | -100.0% |
| Q4 2022 | $7,666,402 | -65.1% | 759,802 | -22.5% | 0.01% | -65.4% |
| Q3 2022 | $21,983,000 | -17.4% | 980,939 | -8.6% | 0.03% | -13.3% |
| Q2 2022 | $26,608,000 | -32.7% | 1,073,793 | +5.0% | 0.03% | -25.0% |
| Q1 2022 | $39,535,000 | -29.3% | 1,022,707 | +7.1% | 0.04% | -21.6% |
| Q4 2021 | $55,895,000 | +3.4% | 955,312 | +4.7% | 0.05% | -3.8% |
| Q3 2021 | $54,065,000 | -52.6% | 912,180 | -30.7% | 0.05% | -51.8% |
| Q2 2021 | $114,181,000 | +4.4% | 1,315,601 | -0.9% | 0.11% | -1.8% |
| Q1 2021 | $109,406,000 | -31.3% | 1,326,945 | -24.2% | 0.11% | -36.7% |
| Q4 2020 | $159,260,000 | +63.7% | 1,751,455 | -28.1% | 0.18% | +41.6% |
| Q3 2020 | $97,304,000 | +10.6% | 2,434,423 | -5.0% | 0.12% | +5.0% |
| Q2 2020 | $87,946,000 | -43.0% | 2,563,271 | -63.1% | 0.12% | -8.5% |
| Q1 2020 | $154,332,000 | +86.5% | 6,948,736 | +64.3% | 0.13% | +30.0% |
| Q4 2019 | $82,764,000 | +45.7% | 4,229,154 | +15.6% | 0.10% | +37.0% |
| Q3 2019 | $56,798,000 | -4.4% | 3,657,320 | +24.9% | 0.07% | -39.2% |
| Q2 2019 | $59,437,000 | +71.4% | 2,927,930 | +48.3% | 0.12% | +51.9% |
| Q1 2019 | $34,686,000 | +105.0% | 1,974,174 | +49.7% | 0.08% | +88.1% |
| Q4 2018 | $16,921,000 | +97.0% | 1,318,860 | +150.1% | 0.04% | +133.3% |
| Q3 2018 | $8,590,000 | +47.2% | 527,320 | +2.5% | 0.02% | +50.0% |
| Q2 2018 | $5,834,000 | +4.0% | 514,480 | -10.5% | 0.01% | 0.0% |
| Q1 2018 | $5,611,000 | +174.4% | 574,890 | +71.8% | 0.01% | +200.0% |
| Q4 2017 | $2,045,000 | +457.2% | 334,680 | +260.7% | 0.00% | +300.0% |
| Q3 2017 | $367,000 | – | 92,790 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 2,073,190 | $26,599,000 | 26.59% |
| Polaris Venture Management Co. V, L.L.C. | 1,823,186 | $23,391,000 | 24.97% |
| Casdin Capital, LLC | 2,550,000 | $32,717,000 | 5.60% |
| Redmile Group, LLC | 10,359,666 | $132,915,000 | 5.34% |
| Aquilo Capital Management, LLC | 697,096 | $8,944,000 | 4.33% |
| Eversept Partners, LP | 165,000 | $2,116,950 | 1.15% |
| Artal Group S.A. | 2,150,000 | $27,585,000 | 1.02% |
| AlpInvest Partners B.V. | 26,925 | $345,000 | 0.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,654,865 | $21,232,000 | 0.85% |
| Lisanti Capital Growth, LLC | 142,760 | $1,832,000 | 0.74% |